NIPER Ph.D. (Pharmacy Practice) FAQs
Ques. What is the research focus of Ph.D. (Pharmacy Practice) at NIPER Guwahati?
Ans. The programme focuses on clinical pharmacy, pharmacovigilance, adverse drug reaction monitoring, drug utilisation studies, pharmacoeconomics, medication adherence, patient counselling, and evidence-based medicine. The department collaborates with hospitals and healthcare institutions in the Northeast India region for clinical research.
Ques. Is NIPER JEE mandatory for Ph.D. (Pharmacy Practice) admission at NIPER Guwahati?
Ans. No. Candidates with valid national fellowships (CSIR-UGC JRF, DBT JRF, ICMR JRF, DST-INSPIRE, or equivalent) can apply for Direct PhD admission without NIPER JEE. However, GPAT/GATE scores are not considered valid for Direct PhD admission.
Ques. What is the minimum duration of the Ph.D. programme at NIPER Guwahati?
Ans. The minimum duration is 3 years (6 semesters). The actual duration may extend depending on research progress and thesis submission.
Ques. Can M.Pharm (Clinical Research) graduates apply for Ph.D. (Pharmacy Practice) at NIPER Guwahati?
Ans. Yes, M.Pharm graduates in Pharmacy Practice, Clinical Research, or equivalent disciplines are eligible to apply, provided they meet the minimum marks criteria and hold a valid national fellowship (for Direct PhD) or qualify NIPER JEE.
Ques. What career opportunities are available after Ph.D. (Pharmacy Practice) from NIPER Guwahati?
Ans. Graduates can pursue careers in clinical research organisations (CROs), hospital pharmacy, pharmacovigilance, regulatory affairs, academic research and teaching, and healthcare policy. The NIPER brand is well-recognized by leading pharmaceutical companies, hospitals, and research institutions.
Ques. Does NIPER Guwahati have hospital affiliations for Pharmacy Practice research?
Ans. Yes, NIPER Guwahati has collaborations with hospitals and healthcare institutions in the Northeast India region, providing PhD scholars in Pharmacy Practice with access to clinical settings for research, patient data collection, and pharmacovigilance studies.
Comments